Patient-reported experiences with side effects of kidney cancer therapies and corresponding information flow

BACKGROUND: Treatment options for metastatic renal cell carcinoma (mRCC) have improved over recent years. Various therapies for metastatic renal cell carcinoma are currently approved for first and successive lines. Having various treatment options makes it important to reflect how patients experienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastrati, Karin, Mathies, Viktoria, Kipp, Anna P., Huebner, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758261/
https://www.ncbi.nlm.nih.gov/pubmed/36525162
http://dx.doi.org/10.1186/s41687-022-00533-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758261/
https://www.ncbi.nlm.nih.gov/pubmed/36525162
http://dx.doi.org/10.1186/s41687-022-00533-z

Ejemplares similares